MAXCYTE, INC. (MXCT)
$1.21-$0.07 (-5.27%) Today
Latest MXCT Insider Trades
Douglas J. Swirsky - Officer
Douglas J. Swirsky - OfficerDouglas J. Swirsky - Officer
Maher Masoud - Officer
Stanley C. Erck
Richard DouglasMaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 16 | 640,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
32 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Joseph Johnston | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| John Joseph Johnston | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Rekha Hemrajani | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Rekha Hemrajani | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Stanley C. Erck | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Stanley C. Erck | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Richard Douglas | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Cynthia Collins | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Cynthia Collins | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| William W. Brooke | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| William W. Brooke | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Patrick J. Balthrop | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Patrick J. Balthrop | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Yasir B. Al-Wakeel | Grant or award | Stock Option (right to buy) | 49,579 | $0.00 | - | |
| Yasir B. Al-Wakeel | Grant or award | Common Stock | 30,421 | $0.00 | - | |
| Parmeet Ahuja - Officer | Grant or award | Common Stock | 187,500 | $0.00 | - | |
| Parmeet Ahuja - Officer | Grant or award | Employee Stock Option (right to buy) | 375,000 | $0.00 | - | |
| Maher Masoud - Officer | Grant or award | Common Stock | 300,000 | $0.00 | - | |
| Maher Masoud - Officer | Grant or award | Employee Stock Option (right to buy) | 600,000 | $0.00 | - | |
| Douglas J. Swirsky - Officer | Open-market sale | Common Stock | 10,142 | $0.82 | $8K | |
| Douglas J. Swirsky - Officer | Open-market purchase | Common Stock | 50,000 | $1.29 | $65K | |
| Maher Masoud - Officer | Open-market purchase | Common Stock | 75,000 | $1.37 | $103K | |
| Stanley C. Erck | Open-market purchase | Common Stock | 100,000 | $1.37 | $137K | |
| Richard Douglas | Open-market purchase | Common Stock | 80,000 | $1.39 | $111K | |
| William W. Brooke | Open-market purchase | Common Stock | 50,000 | $1.29 | $65K | |
| Rekha Hemrajani | Open-market sale | Common Stock | 10,684 | $2.09 | $22K | |
| Cynthia Collins | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Cynthia Collins | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| Yasir B. Al-Wakeel | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Yasir B. Al-Wakeel | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| Rekha Hemrajani | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Rekha Hemrajani | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| Patrick J. Balthrop | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Patrick J. Balthrop | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| John Joseph Johnston | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| John Joseph Johnston | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| Stanley C. Erck | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Stanley C. Erck | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| Richard Douglas | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| Richard Douglas | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| William W. Brooke | Grant or award | Common Stock | 29,210 | $0.00 | - | |
| William W. Brooke | Grant or award | Stock Option (right to buy) | 50,790 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Common Stock | 3,000 | $2.93 | $9K | |
| John Joseph Johnston | Open-market sale | Common Stock | 3,000 | $4.01 | $12K | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 3,000 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Common Stock | 505 | $2.93 | $1K | |
| John Joseph Johnston | Open-market sale | Common Stock | 505 | $3.70 | $2K | |
| John Joseph Johnston | Option exercise | Common Stock | 891 | $2.93 | $3K | |
| John Joseph Johnston | Option exercise | Common Stock | 1,121 | $1.64 | $2K | |
| John Joseph Johnston | Option exercise | Common Stock | 483 | $2.93 | $1K | |
| John Joseph Johnston | Open-market sale | Common Stock | 2,495 | $3.79 | $9K | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 505 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 891 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 1,121 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 483 | $0.00 | - | |
| Stanley C. Erck | Option exercise | Common Stock | 47,689 | $0.04 | $2K | |
| Stanley C. Erck | Open-market sale | Common Stock | 47,689 | $3.72 | $177K | |
| Stanley C. Erck | Option exercise | Employee Stock Option (right to buy) | 47,689 | $0.00 | - | |
| John Joseph Johnston | Option exercise | Common Stock | 3,000 | $2.93 | $9K | |
| John Joseph Johnston | Open-market sale | Common Stock | 3,000 | $3.72 | $11K | |
| John Joseph Johnston | Option exercise | Stock Option (right to buy) | 3,000 | $0.00 | - |
MAXCYTE, INC. (MXCT) had 8 insider filings in the last 90 days, with the most recent on 2026-06-22. The full record for MXCT runs to 32 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of MXCT were filed in the last 90 days. 5 purchases are on record for this company.
No insider sales of MXCT were filed in the last 90 days. 9 sales are on record for this company.
This page tracks MXCT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MXCT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
